Evidence map›Paper›PMID 40994468›Full record

ArticleEuropean heart journal. Case reports2025

Paddling through palpitations: when genes, myocardial inflammation and exercise collide-a case report of arrhythmogenic cardiomyopathy in a young competitive rower.

Boris Delpire, Olivier Ghekiere, Dagmara Dilling-Boer, Pieter Koopman, Guido Claessen

Abstract readCase Reports
In one paragraph

Article in European heart journal. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Boris DelpireJessa Hospital, Department of Cardiology, Hartcentrum, Stadsomvaart 11, 3500 Hasselt, Belgium.ORCID https://orcid.org/0000-0003-1887-6919
Olivier GhekiereUHasselt, Faculty of Medicine and Life Sciences/LCRC, Agoralaan, 3590 Diepenbeek, Belgium.ORCID https://orcid.org/0000-0002-9229-9489
Dagmara Dilling-BoerJessa Hospital, Department of Cardiology, Hartcentrum, Stadsomvaart 11, 3500 Hasselt, Belgium.ORCID https://orcid.org/0000-0002-6427-5877
Pieter KoopmanJessa Hospital, Department of Cardiology, Hartcentrum, Stadsomvaart 11, 3500 Hasselt, Belgium.ORCID https://orcid.org/0000-0002-6373-180X
Guido ClaessenJessa Hospital, Department of Cardiology, Hartcentrum, Stadsomvaart 11, 3500 Hasselt, Belgium.ORCID https://orcid.org/0000-0001-8261-6666

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Arrhythmogenic cardiomyopathy (ACM) is characterized by fibrofatty replacement of myocardium, predisposing to ventricular arrhythmias and sudden cardiac death. Arrhythmogenic cardiomyopathy is often linked to desmosomal gene mutations, particularly PKP2, which encodes plakophilin-2, a key structural protein in cardiac intercalated discs. In individuals with PKP2 mutations, exercise has been shown to accelerate disease progression. Case summary: A 22-year-old male semi-professional rower presented with palpitations, pre-syncope, and a history of presumed myocarditis with subepicardial fibrosis on cardiac magnetic resonance (CMR). Workup revealed anterior T-wave inversions on resting ECG and sustained monomorphic right ventricular (RV) outflow tract tachycardia, induced during exercise testing. Repeat CMR showed RV dysfunction and non-ischaemic RV and LV fibrosis with fibrofatty replacement. The patient met diagnostic criteria for biventricular ACM and underwent catheter ablation targeting the arrhythmic substrate. A multidisciplinary team carefully considered ICD therapy. However, due to the limited extent of the arrhythmic substrate, the exercise-induced nature of the ventricular tachycardia, and the successful ablation, ICD implantation was deferred at this stage. An ILR was implanted for continuous rhythm monitoring, with a low threshold for future ICD placement. High-intensity sports restriction, pharmacological therapy, and genetic counselling were initiated. Genetic testing identified a pathogenic PKP2 mutation. Discussion: This case highlights the complex interplay of genetic predisposition, myocardial inflammation, and exercise in ACM expression. The presumed myocarditis likely represented a 'hot phase' of ACM, accelerating structural cardiac changes. High-intensity exercise then acted as a 'second hit,' triggering phenotypic expression. Multidisciplinary evaluation combining rhythm monitoring, imaging, and genetic testing was key to diagnosis and management.

Indexed as

Arrhythmogenic cardiomyopathyCase reportMyocarditisPKP2Sports cardiologyVentricular arrhythmias

Identifiers

PMID40994468
PMCPMC12456407

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.